Change search
ReferencesLink to record
Permanent link

Direct link
Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia
Show others and affiliations
2013 (English)In: Genome Biology, ISSN 1465-6906, E-ISSN 1465-6914, Vol. 14, no 9, Article number: r105- p.Article in journal (Refereed) Published
Abstract [en]

Background: Although aberrant DNA methylation has been observed previously in acute lymphoblastic leukemia (ALL), the patterns of differential methylation have not been comprehensively determined in all subtypes of ALL on a genome-wide scale. The relationship between DNA methylation, cytogenetic background, drug resistance and relapse in ALL is poorly understood. Results: We surveyed the DNA methylation levels of 435,941 CpG sites in samples from 764 children at diagnosis of ALL and from 27 children at relapse. This survey uncovered four characteristic methylation signatures. First, compared with control blood cells, the methylomes of ALL cells shared 9,406 predominantly hypermethylated CpG sites, independent of cytogenetic background. Second, each cytogenetic subtype of ALL displayed a unique set of hyper- and hypomethylated CpG sites. The CpG sites that constituted these two signatures differed in their functional genomic enrichment to regions with marks of active or repressed chromatin. Third, we identified subtype-specific differential methylation in promoter and enhancer regions that were strongly correlated with gene expression. Fourth, a set of 6,612 CpG sites was predominantly hypermethylated in ALL cells at relapse, compared with matched samples at diagnosis. Analysis of relapse-free survival identified CpG sites with subtype-specific differential methylation that divided the patients into different risk groups, depending on their methylation status. Conclusions: Our results suggest an important biological role for DNA methylation in the differences between ALL subtypes and in their clinical outcome after treatment.

Place, publisher, year, edition, pages
BioMed Central, 2013. Vol. 14, no 9, Article number: r105- p.
National Category
Medical Genetics Microbiology in the medical area
URN: urn:nbn:se:umu:diva-85339DOI: 10.1186/gb-2013-14-9-r105ISI: 000328195700011OAI: diva2:692660
Swedish Foundation for Strategic Research , RBc08-008Swedish Cancer Society, CAN2010/592Formas
Available from: 2014-01-31 Created: 2014-01-31 Last updated: 2014-01-31Bibliographically approved

Open Access in DiVA

fulltext(2676 kB)79 downloads
File information
File name FULLTEXT01.pdfFile size 2676 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Forestier, Erik
By organisation
Medical and Clinical Genetics
In the same journal
Genome Biology
Medical GeneticsMicrobiology in the medical area

Search outside of DiVA

GoogleGoogle Scholar
Total: 79 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 44 hits
ReferencesLink to record
Permanent link

Direct link